Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple C2 and transmembrane domain-containing protein 1 (MCTP1) is a member of a conserved protein family that contains three high-affinity calcium-binding C2 domains and two transmembrane regions, anchoring it permanently in intracellular membranes, including the endoplasmic reticulum[1][2][4][5]. MCTP1 is highly expressed in the central nervous system, particularly in neuronal cell bodies and pre-synaptic axon terminals, where it localizes to secretory vesicles and endosomes[1][2]. Its unique C2 domains function as calcium sensors, influencing synaptic vesicle retrieval and homeostatic synaptic plasticity, and regulating endocytic recycling processes at neuronal synapses[1][2][4]. MCTP1 also plays a role in lipid droplet biogenesis by remodeling ER membrane curvature and facilitating contacts between organelles[5][7]. Genetic variants in MCTP1 have been associated with neuropsychiatric disorders such as bipolar disorder[2]. No established small-molecule or biologic drugs directly target this protein, nor is it used clinically as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple C2 and transmembrane domain-containing protein 1 (MCTP1).